FilingReader Intelligence
Piramal and NewAmsterdam invest millions in Pennsylvania facility
August 21, 2025 at 07:03 PM UTC•By FilingReader AI
Piramal Pharma Solutions and NewAmsterdam Pharma are making a multi-million-dollar investment in a dedicated oral solid dosage suite at PPS's Sellersville, Pennsylvania facility.
The new suite will support multi-layer tablet production, particularly for NewAmsterdam Pharma's fixed dose combination of obicetrapib and ezetimibe, and create over 20 jobs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:PPLPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when PIRAMAL PHARMA publishes news
Free account required • Unsubscribe anytime